老虎證券

BUZZ-Organon rises after agreeing to sell postpartum bleeding device to Laborie for up to $465 mln

Reuters
2025/11/07
BUZZ-Organon rises after agreeing to sell postpartum bleeding device to Laborie for up to $465 mln

** Shares of healthcare firm Organon OGN.N rise 2% to $6.85 premarket

** Co says it will sell its JADA System, a device used to treat postpartum bleeding, to Laborie Medical Technologies for up to $465 million

** Deal includes $440 mln upfront, $25 mln tied to 2026 sales targets – OGN

** OGN says ~100 of it's employees will move to Laborie as part of the agreement

** The JADA System, which OGN acquired in 2021, is used to manage postpartum hemorrhage, a serious complication after childbirth - OGN

** The transaction is expected to close in the first quarter of 2026, pending regulatory approvals, co says

** Up to last close, stock down ~55% YTD

(Reporting by Sahil Pandey in Bengaluru)

((Sahil.Pandey@thomsonreuters.com))

應版權方要求，你需要登入查看該內容

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10